Primary human AML cells (De novo AML 6373, harboring FLT3-ITD mutation) were collected by leukapheresis from AML patients at the University Hospital, University of Pennsylvania, with informed consents obtained per IRB (IRB protocol 703185). Here, FLT3 is linked to acute myeloid leukemia.